Up to $5,000,000 based on stage and scope of research. - Monday,September 14, 2026 (LOI)
Alzheimer's Drug Discovery FoundationThis RFP supports investigational new drug (IND)-enabling studies (or the international equivalent) and earlyphase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease (AD) and related dementias.
